Form 4 for INMB Inmune Bio, Inc.
Accepted 2022-05-31 00:00:00 ET · period of report 2022-05-26 · accession 0001213900-22-030210 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-31 | 2022-05-26 | INMB | Tesi Raymond Joseph | Pres, CEO, Dir, 10% | P - Purchase | $6.41 | +6,300 | 1.52M | +0.4% | +$40.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-26 | P | A | 6,300 | $6.41 | 1,520,698 | D | — | — | (F1) Represents the average purchase price at a range of between $6.37 and $6.43 per share. |